A. Cubitt

Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN)

W. Dougall, M. Smyth, B. Hughes, 2019, Trials.

Changes in Self-Disclosure Behavior Following an Intensive "Encounter" Group Experience

C. Brasfield, A. Cubitt, 2012 .

Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent

A. Coulthard, M. Griffin, P. Vasey, 2010, British Journal of Cancer.

Teletrials, the new norm? Expert recommendations for teletrials into the future: Findings from the Clinical Oncology Society of Australia Clinical Trial Research Professionals Group Workshop

S. Sabesan, B. Morris-Smith, C. Underhill, 2022, Asia-Pacific journal of clinical oncology.

‘How long is the piece of string?’ – How patients negotiate the uncertainties of a Neuroendocrine tumour diagnosis

Matthew Burge, David Wyld, Stefanie Plage, 2017 .